Skip to content

Neuronetics STIM Net Income

Net Income at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$14.24M+1,909%
LBR
LB Pharmaceuticals Inc Common StockLBRX
-$19.05M-259%
Stereotaxis logo
StereotaxisSTXS
-$5.86M-0.7%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$6.69M-1.5%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$197.9M+2,405%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$9.55M-58.5%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's net income?
Neuronetics (STIM) reported net income of -$10.78M in Q1 2026.
How has Neuronetics's net income changed year-over-year?
Neuronetics's net income increased by 15.0% year-over-year, from -$12.69M to -$10.78M.
What is the long-term trend for Neuronetics's net income?
Over 4 years (2021 to 2025), Neuronetics's net income has grown at a 5.8% compound annual growth rate (CAGR), from -$31.19M to -$39.14M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.